Access this stock data via API
Subscribe
Hofseth Biocare ASA
0
0
0%

Financials

Income statement

Fiscal date 2024 2023 2022 2021
Total reported revenue 257.4M 194.9M 120.4M 87.6M
Cost of revenue 169.6M 150.7M 91.9M 64.5M
Gross profit 87.9M 44.2M 28.5M 23.1M
Operating expense
Research & development 9.3M 11.0M 13.6M 8.9M
Selling general and admin 43.0M 35.5M 32.9M 36.0M
Other operating expenses 33.1M 25.5M 21.1M 23.0M
Operating income -113.2M -126.2M -128.6M -118.6M
Non operating interest income
Income 790K 550K 651K 613K
Expense 15.7M 7.5M 10.0M 9.4M
Other income expense
Pretax income -125.3M -106.7M -137.4M -126.5M
Tax provision 0 0 0 0
Net income -125.3M -106.7M -137.4M -126.5M
Basic EPS -0.3 -0.3 -0.4 -0.4
Diluted EPS -0.3 -0.3 -0.4 -0.4
Basic average shares 416.3M 395.1M 374.7M 357.8M
Diluted average shares 416.3M 395.1M 374.7M 357.8M
EBITDA -78.0M -86.4M -97.0M -87.7M
Net income from continuing op. -125.3M -106.7M -137.4M -126.5M
Minority interests 2K -1K -1K 1K
Preferred stock dividends 0 0 0 0
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed
Main market opens in 9 hours 10 minutes

23:49
00:00
09:00
16:20
23:59

Trading Hours (Monday - Friday):

Main market
09:00 - 16:20
All times are displayed in the Europe/Oslo timezone (CET, UTC+01:00).